title: Efficacy of rituximab in combination with steroids in refractory chronic lymphocytic leukemia.
authors.forename: J P
authors.initials: JP
authors.lastname: Quinn
authors.forename: S
authors.initials: S
authors.lastname: Mohamedbhai
authors.forename: K
authors.initials: K
authors.lastname: Chipperfield
authors.forename: M
authors.initials: M
authors.lastname: Treacy
authors.forename: S
authors.initials: S
authors.lastname: D'Sa
authors.forename: A C
authors.initials: AC
authors.lastname: Nathwani
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D016879:Salvage Therapy; D013256:Steroids / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D013256:Steroids; D000069283:Rituximab